MarginsXMarginsX
Home › Markets › Health Care › MNOV

Medicinova Inc (MNOV)

MNOV trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.34
-3.94% on the day
Market cap
$68.7M
Micro cap
Revenue · 2025
$410K
Prior year not contiguous
Net income · 2025
-$12.0M
-2928.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1226616/000119312526100432/0001193125-26-100432-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMNOV on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001226616
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$410K
Net income-$12.0M
Operating income-$13.3M
Net margin-2928.8%
Operating margin-3242.5%
Revenue growthNo prior-year revenue to compare
Cash$30.8M
Total assets$45.6M
P/E (computed)Net income was not positive
P/S (computed)167.6×

Warning signs

Cash runway
35.9 months
$29.3M cash at September 30, 2026
Share count, 1 year
+4.5%
2025-11-12 to 2026-11-10 · +4.5% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
-$1.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$29.3M cash; operating cash flow -$2.4M a quarter.Report 2026-09-30
Shares outstanding51,232,668 (2026-11-10); 49,046,246 a year earlier; 49,046,246 three years earlier.Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-30
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBDO USA, P.C., San Diego, California, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $1.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$139K-$2.8M-$2.4M$29.3MNo debt tags$936K10-Q 2026-11-12
Q2 2026
2026-06-30
$458K-$2.3M-$1.9M$25.4MNo debt tags$920K10-Q 2026-08-13
Q1 2026
2026-03-31
$187K-$2.6M-$3.5M$27.3MNo debt tags$597K10-Q 2026-05-14
Q4 2025
2025-12-31
$152K-$2.8M-$2.0M$30.8MNo debt tags$410K10-K 2026-03-10
Q3 2025
2025-09-30
$123K-$3.1M-$1.7M$32.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
$135K-$3.3M-$2.3M$34.3MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$2.9M-$3.8M$36.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
Not filed-$2.8M-$1.9M$40.4MNo debt tagsNeeds four quarters10-K 2026-03-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-12-30
Latest annual report10-K2026-03-10
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 881 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.1%
1 month-6.7%
3 months+6.9%
Year to date+6.9%
1 year-9.1%
From 52-week high-59.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ZYBTZhengye Biotechnology Holding Limited$1.43-4.67%$67.8M
CRBPCorbus Pharmaceuticals Holdings Inc.$3.38-0.44%$69.5M
TENXTenax Therapeutics Inc.$1.48-8.64%$67.4M
GOSSGossamer Bio Inc.$10.98+0.09%$67.2M
COYACoya Therapeutics Inc.$3.00-4.15%$70.4M
VTVTvTv Therapeutics Inc.$17.69-10.16%$71.0M
TLSATiziana Life Sciences Ltd. Common Shares$0.5762+1.11%$73.3M
KALAKALA BIO Inc.$3.83-8.02%$74.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier